Back to search
Heparin-induced Thrombocytopenia (HIT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heparin-induced Thrombocytopenia (HIT) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Heparin-induced Thrombocytopenia (HIT) trials you may qualify forThe investigators would like to analyze platelet/leukoplak activation, quantify and morphologically characterize these aggregates using in vitro analysis, direc…
The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to hepa…
The purpose of this study is to collect data on the clinical management of Argatroban in patients with suspected or confirmed heparin-induced thrombocytopenia T…
The purpose of this study is to evaluate the efficacy and safety of VLX-1005, a 12-lipoxygenase (12-LOX) enzyme inhibitor in treating heparin induced thrombocyt…
Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin therapy with a non-negligible incidence (estimated at 2.6% of unfractionated heparin…